Rahul Banerjee, MD, FACP (@rahulbanerjeemd@med-mastodon.com)
1 Post, 4 Following, 2 Followers · Assistant Professor at the University of Washington / Fred Hutchinson Cancer Center (Seattle, WA). #MMsm myeloma and CAR-T therapy.
1 Post, 4 Following, 2 Followers · Assistant Professor at the University of Washington / Fred Hutchinson Cancer Center (Seattle, WA). #MMsm myeloma and CAR-T therapy.
Bispecific antibodies have meaningfully expanded the therapeutic armentarium in multiple myeloma. Talquetamab is a CD3+ T cell redirecting antibody targeting GPRC5D, which is expressed on…
International Myeloma Working Group (IMWG) response criteria require refrigerated 24-hour urine specimens for most patients. However, given that serum free light chain testing has been…
Background: The diagnostic utility of repeat kidney biopsy in AL amyloidosis patients in complete (CR) or very good partial hematologic response (VGPR) but with renal…
What can myeloma consults and second opinions bring to patients? Dr. Ola Landgren shares his perspective on the benefits.
Amp(1q), HRCA ≥2, high CTC levels, and a longer time to reach first MRD negativity are significant predictors of unsustained MRD negativity.Maintenance treatmen
Plus, a bone-marrow-transplant revolution, and why fewer college football players are entering the NFL draft.
The 2024 ASCO Annual Meeting is funded through Conquer Cancer®, the ASCO Foundation, by these sponsorship donors. Bristol Myers Squibb Daiichi Sankyo,
The 2024 ASCO Annual Meeting is funded through Conquer Cancer®, the ASCO Foundation, by these sponsorship donors. Bristol Myers Squibb Daiichi Sankyo,
Emily Whitehead has been in remission since 2012 after receiving CAR T-cell therapy to treat her leukemia.
This value you provided is not a number. Please try again. This value you provided is not an integer. Please try again. The value enter…